Treatments Against RA and Effect on FDG-PET/CT

NCT02374021 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

159

Enrollment

OTHER

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Methotrexate
DRUG: Sulfasalazine
DRUG: Hydroxychloroquine
DRUG: Etanercept
DRUG: Adalimumab

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]